Highlights from the journal CHEST®, May 2023

Glenview, Illinois – Published monthly, the journal CHEST ^® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care and sleep medicine and related disciplines. Journal topics include asthma, chest infections, COPD, critical care, diffuse lung disease, education and clinical practice, pulmonary vascular disease, sleep, thoracic oncology and the humanities.

The May issue of the CHEST journal contains 50 articles, including clinically relevant research, reviews, case series, commentary and more. Each month, the journal also offers complementary web and multimedia resources, including visual abstracts, to expand the reach of its most interesting, timely and relevant research.

“To raise awareness for cystic fibrosis in May, in addition to the research included in the latest issue, I recommend visiting the journal’s Adult Cystic Fibrosis Series,” says Editor in Chief of the journal, Peter Mazzone, MD, MPH, FCCP. “One of the four available journal CHEST Special Series, the grouping around adult cystic fibrosis examines a once fatal childhood condition (>90% mortality rate in the first year of life) that is now a disease across the age spectrum, including adulthood.”

Also included in the current issue of the journal CHEST:

• Asthma
  “A Total Diet Replacement Weight Management Program for Difficult-to-Treat Asthma Associated With Obesity” shows that over 16 weeks, the Counterweight-Plus Programme resulted in clinically relevant improvements in both asthma control and quality-of-life indexes, with substantial weight loss, as compared with usual care. View the visual abstract for this research.
• Critical Care
  Looking at targeted temperature management in the ICU, “Differential Effect of Targeted Temperature Management Between 32 °C and 36 °C Following Cardiac Arrest According to Initial Severity of Illness” finds 32 °C to 36 °C was significantly associated with better outcomes in patients with low and high severity Cardiac Arrest Hospital Prognosis score at ICU admission. View the visual abstract for this research.
• Education and Clinical Practice
  A pilot randomized, controlled trial, “Nebulized vs IV Tranexamic Acid for Hemoptysis,” suggests nebulized tranexamic acid may be more efficacious than IV tranexamic acid in reducing the amount of hemoptysis and the need for interventional procedures in the ED. View the visual abstract for this research. Listen to a podcast of the experts discussing their findings.
• Thoracic Oncology
  Assessing the relationship between pulmonary nodules (PNs) and lung cancer in the Medicare population, “Pulmonary Nodules, Lung Cancer Screening, and Lung Cancer in the Medicare Population” suggests PNs represent a relatively common presentation of potentially curable lung cancer. Listen to a podcast of the experts discussing their findings.

To view the entire May issue of the CHEST journal, visit journal.chestnet.org, and follow @journal_CHEST on Twitter for the latest journal news.

About the American College of Chest Physicians

The American College of Chest Physicians^® (CHEST) is the global leader in the prevention, diagnosis and treatment of chest diseases. Its mission is to champion advanced clinical practice, education, communication and research in chest medicine. It serves as an essential connection to clinical knowledge and resources for its 19,000+ members from around the world who provide patient care in pulmonary, critical care and sleep medicine. For information about the American College of Chest Physicians, and its flagship journal CHEST^®, visit chestnet.org.